Vijaya Diagnostic Centre Ltd

Stage 2 · Advancing · week 22Setup 4.4 WatchEven +0.6

As of 16 Oct 2026, Vijaya Diagnostic Centre is in Stage 2 — advancing, the uptrend phase, in week 22 (since 14 May 2026). It closed at ₹1,382, 12.0% below its 52-week high and above its 200-day average, which is rising. In Health Care, 40.0% of stocks are in Stage 2.

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. More about the company

₹1,381.7
-0.41% today
₹14,231 Cr · Mid cap
Market Neutral — FadingHealth Care 40.0% in Stage 2-7.4 pts / 20dHospitals & Diagnostic Centres 19.4%-19.4 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

4.4 Watch

Momentum

Steady

Edge

Even +0.6

Setup-score rank among Stage 2 peers: #4 of 6 in Hospitals & Diagnostic Centres · #40 of 70 in Health Care

Is VIJAYA early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-12.0%
₹861.4 lo₹1,570.7 hi
12.0% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 22
1w13w26w
Week 22 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
13.6%
200 DMA: ₹1,216.6 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
2.19x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -2.1% vs MA50 +3.0%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-3.9%
3M
+3.0%
6M
+35.6%
YTD
+37.8%
1Y
+39.5%
Sector
Health Care
↓ Peaking
Stage 2%
40.0%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
This stock ranks #21 of 66 Stage 2 stocks in Health Care by RS.
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
19.4%
20d Δ
-19.4pp
1M return
-10.4%
3M return
-12.2%
Industry Stage-2 % · last 20 days
Ranks #1 of 5 Stage 2 stocks in this industry. Top stock in industry.
Stage Cycle Timeline2023-07-20 → 2026-10-16
S2 35w
S2 41w
S3 15w
S2 22w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 1w → S2 35w → S3 5w → S2 41w → S3 15w → S4 9w → S1 5w → S2 5w → S3 8w → S4 2w → S3 1w → S2 4w → S4 13w → S1 2w → S2 22w current
Total tracked: 168 weeks across 15 stage runs.
Scan Membership
Prop Scan
Latest: 2026-09-16
Pullback Hunter
Latest: 2026-08-07
60 appearances in last 60 days. First seen: 2026-06-17.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S2
Wk 22 · Vol 2.19x
2026-10-15S2
Wk 22 · Vol 0.76x
2026-10-14S2
Wk 22 · Vol 0.44x
2026-10-13S2
Wk 22 · Vol 0.69x
2026-10-12S2
Wk 22 · Vol 0.41x
2026-10-09S2
Wk 21 · Vol 0.26x
2026-10-08S2
Wk 21 · Vol 0.49x
2026-10-07S2
Wk 21 · Vol 0.48x
2026-10-06S2
Wk 21 · Vol 0.76x
2026-10-05S2
Wk 21 · Vol 0.90x
2026-10-01S2
Wk 20 · Vol 1.08x
2026-09-30S2
Wk 20 · Vol 0.41x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹1,471.8
200 DMA
₹1,216.6
52W High
₹1,570.7
52W Low
₹861.4
5D Low
₹1,381.7
Resistance levels (recent highs)
20d High
₹1,570.7
60d High
₹1,570.7
120d High
₹1,570.7
250d High
₹1,570.7
Next resistance
+13.7%
to 20d High
Ask the Market AI about VIJAYAAsk →
P/E (TTM)
75.3
Forward 48.2
Earnings Growth (YoY)
+22.5%
Revenue +21.4%
Dividend Yield
0.17%
P/B 15.0
About this companyHealth Care· Hospitals & Diagnostic Centres

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.